Capricor Therapeutics, Inc. (CAPR) vs YD Bio Limited (YDES)

Capricor Therapeutics, Inc. CAPR 6.95 −6.96%
YD Bio Limited YDES 6.08 −3.95%

Capricor Therapeutics, Inc. and YD Bio Limited are both Biotechnology companies. Capricor Therapeutics, Inc. and YD Bio Limited are of similar size ($476.8M and $455.2M).

Metric	CAPR	YDES	Biotechnology median
P/E	n/m	—	8.56
P/S	19.43	—	10.17
P/B	1.76	—	2.34
Price to free cash flow	3.31	—	20.42
EV/EBITDA	n/m	—	0.69
EV/Sales	9.38	—	9.64
Earnings yield	(32.80%)	—	(29.41%)
Free cash flow yield	30.25%	—	(23.50%)

Metric	CAPR	YDES	Biotechnology median
Gross margin	100.00%	—	65.16%
Operating margin	0.00%	—	0.00%
Net margin	0.00%	—	0.00%
Free cash flow margin	0.00%	—	0.00%
Return on equity	(73.70%)	—	(56.66%)
Return on assets	(51.53%)	—	(49.22%)
Return on invested capital	(1,019.73%)	—	0.00%

Metric	CAPR	YDES	Biotechnology median
Revenue growth (TTM)	(11.55%)	—	5.64%
EPS growth (last fiscal year)	(96.52%)	—	30.08%
Revenue growth, 5-year CAGR	85.83%	—	9.41%
Net income growth, 5-year CAGR	0.00%	—	0.00%

Metric	CAPR	YDES	Biotechnology median
Debt to equity	0.00	—	0.00
Current ratio	7.35	—	4.72
Net debt to EBITDA	2.99	—	0.96

Metric	CAPR	YDES	Biotechnology median
Dividend yield	—	—	0.08%
Payout ratio	—	—	—

Metric	CAPR	YDES	Biotechnology median
Market cap	455.23m	476.77m	151.40m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack